Assessing risk and benefit communication in direct-to-consumer medication website advertising

Drug Information Journal

Volumn 39, Issue 1, 2005, Pages 3-12

  Vigilante Jr , William J ^a   Wogalter, Michael S ^b  

^a Robson Forensic Inc   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Direct to Consumer; Prescription medications; Website advertisement

Indexed keywords

CELECOXIB; MONTELUKAST;

ADVERTIZING; ARTHRITIS; ARTICLE; ASTHMA; CONSUMER; CONTROLLED STUDY; DIRECT TO CONSUMER ADVERTIZING; DRUG MANUFACTURE; DRUG MARKETING; FEMALE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RECALL; RECOGNITION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TIME;

EID: 13844264282     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150503900102     Document Type: Article

References (11)

1. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs. 2000;19:110-128.
2. Food and Drug Administration. Prescription-drug advertisements (Federal Register, Title 21 Vol. 4, Parts 200-299). Washington, DC: U.S. Government Printing Office; 1999.
3. Frantz JP, Rhoades TP. A task-analytic approach to the temporal and spatial placement of product warnings. Human Factors. 1993;35:719-730.
4. Wogalter MS, Smith-Jackson TL, Mills BJ, Paine CS. The effects of print format in Direct-to-Consumer prescription drug advertisements on risk knowledge and preference. Drug Inf J. 2002;36:693-705.
5. Tiller EW, Green P. How to make your Website fast and usable. Proceedings of the Human Factors and the web 5th Annual Meeting. Santa Monica, CA: Human Factors and Ergonomics Society; 1999.
6. Chen B. Design and validation of a user-centered web browser (Doctoral dissertation, Purdue University, 1998). Dissertation Abstracts International. 1999;59:3633.
7. Hicks K, Wogalter MS, Vigilante WJ. Placement of benefits and risks in prescription drug manufacturers' Websites and information source expectations. Drug Inf J. 2004.
8. Lynch PJ, Horton S. Web Style Guide: Basic Design for Creating Websites. New Haven, CT: Yale University Press; 1999.
9. Center for Drug Evaluation and Research: Division of Drug Marketing, Advertising, and Communications. Warning Letters and Notice of Violation Letters to Pharmaceutical Companies, 2003. http://www.fda.gov/cder/warn/index.htm
10. Vigilante WJ, Wogalter MS. Direct-to-consumer (DTC) advertising of prescription medications on the World Wide web: assessing the communication of risks. Proceedings of the Human Factors and Ergonomics Society 45th Annual Meeting. Santa Monica, CA: Human Factors and Ergonomics Society; 2001;1279-1283.
11. Vigilante WJ. Direct-to-Consumer (DTC) advertising of prescription medications on the World Wide Web: assessing the communication of risks and benefits browser (Doctoral dissertation, North Carolina State University, 2001). Dissertation Abstracts International. 2001;63:341.